/Companies

Biotech Startups

11,050 companies tagged Biotech, with their investors and founders.

Cytonics

Cytonics develops biologic therapies targeting osteoarthritis, with lead candidate CYT-108, a recombinant protease inhibitor for knee joint regeneration based on a novel pathway to restore cartilage-secreting cells. The company funds development through equity crowdfunding from individual investors rather than venture capital.

0 investors

Cytonus Therapeutics

0 investors

CytoSite BioPharma

0 investors

Cytotest

0 investors

Cytovia Holdings

0 investors

Cytrx

0 investors

Dahlia Biosciences

0 investors

Dairyvative Technologies

0 investors

DalCor Pharmaceuticals US

0 investors

Dalix Therapeutics

0 investors

Dance Biopharm

0 investors

Dance Biopharm Holdings

0 investors

DARA BioSciences

0 investors

Dare Bioscience

Daré Bioscience is a female-led biotech company developing treatments for women's health conditions that are overlooked in the healthcare industry. The company uses rigorous clinical trial methods and evidence-based research to bring FDA-approved and pipeline therapeutics to patients through both traditional regulatory pathways and compounding services.

0 investors

Dauntless 1

0 investors

Dauntless 2

0 investors

Decoy Biosystems

0 investors

Decoy Therapeutics

Decoy Therapeutics is a pre-clinical stage biotechnology company developing peptide conjugate therapeutics using its proprietary IMP³ACT platform, which combines machine learning and artificial intelligence with high-speed synthesis to engineer treatments targeting infectious diseases and oncology.

0 investors

Deep Apple

Deep Apple Therapeutics is discovering small-molecule drug candidates using cryo-EM structural biology, artificial intelligence, and virtual screening to identify compounds for various diseases. The company serves pharmaceutical development and biomedical research.

0 investors

Deep Blue Medical Advances

0 investors

Delcath Systems

Delcath Systems is a commercial-stage interventional oncology company developing minimally-invasive treatments for patients with primary and metastatic liver cancers. Its FDA-approved therapy targets adult patients with metastatic uveal melanoma, marketed in the US and Europe.

0 investors

DeliverCareRX

0 investors

Delphinus Medical Technologies

0 investors

Deltagen BioServices

0 investors

Other sectors & tags

Biotech Startups — Page 378 | Fundraising Fox